University of Minnesota. Driven to Discover.
Steeply dropping cases, though, may cause the NIAID to vary from the original trial design.
Faced with new data, the ACIP drops its preference for nasal-spray flu vaccine in 2- to 8-year-olds.
The WHO notes signs that flu strains, especially avian ones, are co-circulating at unprecedented levels.
Presidential panel finds "a failure to prepare and a failure to follow good science."
A Scottish study of this year's vaccine found effectiviness of 33%, higher than elsewhere.
Two experts cite a perceived lack of public and global input, as well as potential conflict of interest.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.